This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kassis, J. Articles by Wells, A. Search for Related Content PubMed PubMed Citation Articles by Kassis, J. Articles by Wells, A.

A Role for Phospholipase C--mediated Signaling in Tumor Cell Invasion¹

Pathology and Laboratory Medicine Service, Birmingham Veterans Administration Medical Center, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007 [J. K., J. M., H. L., H-G. K., A. W.], and Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030 [N. M. G.]

The invasive and metastatic transformation of cancers often results in death. However, the mechanisms that promote this transformation remain unclear. Two closely related receptors, the epidermal growth factor receptor (EGFR) and ErbB2, are overexpressed in a significant percentage of breast and prostate carcinomas, among others, with this up-regulated signaling correlating with tumor progression. Previous studies in our laboratory have demonstrated that an EGFR-phospholipase C (PLC)-mediated motility-associated signaling pathway is rate-limiting for tumor cell invasion in vitro and in vivo in one model of prostate carcinoma. Therefore, we investigated whether this PLC signaling pathway also was rate-limiting for invasion in other tumor cell lines and types and whether this EGFR activity is subsumed by the closely related ErbB2. We determined the effects of PLC signal abrogation by pharmacological (U73122) and molecular (expression of the dominant-negative PLCz) means on the in vitro invasiveness of tumor cells. Inhibition of PLC signaling concomitantly decreased invasiveness of de novo-occurring transgenic adenocarcinoma mouse prostate (TRAMP) lines and the human breast cancer cell lines MDA-468 and MDA-231; these lines present up-regulated EGFR signaling. Because the prostate and breast cancer lines usually present autocrine stimulatory loops involving EGFR, we also examined transgenic adenocarcinoma mouse prostate C1 and MDA-468 treated with the EGFR-specific kinase inhibitor PD153035 to determine whether invasiveness is dependent on EGFR signaling. PD153035 reduced invasiveness to levels similar to those seen with U73122, suggesting that the autocrine EGFR stimulatory loop is functioning to promote invasiveness. To determine whether this signaling pathway also promotes invasiveness of ErbB2-overexpressing tumors, we examined the human breast carcinoma line MDA-361; again, U73122 inhibition of PLC decreased invasiveness. In all situations, the inhibition of PLC signaling did not decrease mitogenic signaling. Thus, the motility-associated PLC signaling pathway is a generalizable rate-limiting step for tumor cell progression.

This article has been cited by other articles:

				H. Nozawa, G. Howell, S. Suzuki, Q. Zhang, Y. Qi, J. Klein-Seetharaman, A. Wells, J. R. Grandis, and S. M. Thomas Combined Inhibition of PLC{gamma}-1 and c-Src Abrogates Epidermal Growth Factor Receptor-Mediated Head and Neck Squamous Cell Carcinoma Invasion Clin. Cancer Res., July 1, 2008; 14(13): 4336 - 4344. [Abstract] [Full Text] [PDF]

				M. Sidani, D. Wessels, G. Mouneimne, M. Ghosh, S. Goswami, C. Sarmiento, W. Wang, S. Kuhl, M. El-Sibai, J. M. Backer, et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells J. Cell Biol., November 19, 2007; 179(4): 777 - 791. [Abstract] [Full Text] [PDF]

				N. P. Jones and M. Katan Role of Phospholipase C{gamma}1 in Cell Spreading Requires Association with a {beta}-Pix/GIT1-Containing Complex, Leading to Activation of Cdc42 and Rac1 Mol. Cell. Biol., August 15, 2007; 27(16): 5790 - 5805. [Abstract] [Full Text] [PDF]

				V. Bertagnolo, M. Benedusi, F. Brugnoli, P. Lanuti, M. Marchisio, P. Querzoli, and S. Capitani Phospholipase C-{beta}2 promotes mitosis and migration of human breast cancer-derived cells Carcinogenesis, August 1, 2007; 28(8): 1638 - 1645. [Abstract] [Full Text] [PDF]

				H. Shao, J. Chou, C. J. Baty, N. A. Burke, S. C. Watkins, D. B. Stolz, and A. Wells Spatial Localization of m-Calpain to the Plasma Membrane by Phosphoinositide Biphosphate Binding during Epidermal Growth Factor Receptor-Mediated Activation. Mol. Cell. Biol., July 1, 2006; 26(14): 5481 - 5496. [Abstract] [Full Text] [PDF]

				D. Srinivasan and R. Plattner Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells Cancer Res., June 1, 2006; 66(11): 5648 - 5655. [Abstract] [Full Text] [PDF]

				Y.-C. Lien, T. Noel, H. Liu, A. J. Stromberg, K.-C. Chen, and D. K. St. Clair Phospholipase C-{delta}1 Is a Critical Target for Tumor Necrosis Factor Receptor-Mediated Protection against Adriamycin-Induced Cardiac Injury. Cancer Res., April 15, 2006; 66(8): 4329 - 4338. [Abstract] [Full Text] [PDF]

				N. P. Jones, J. Peak, S. Brader, S. A. Eccles, and M. Katan PLC{gamma}1 is essential for early events in integrin signalling required for cell motility J. Cell Sci., June 15, 2005; 118(12): 2695 - 2706. [Abstract] [Full Text] [PDF]

				V. DesMarais, M. Ghosh, R. Eddy, and J. Condeelis Cofilin takes the lead J. Cell Sci., January 1, 2005; 118(1): 19 - 26. [Abstract] [Full Text] [PDF]

				G. Mouneimne, L. Soon, V. DesMarais, M. Sidani, X. Song, S.-C. Yip, M. Ghosh, R. Eddy, J. M. Backer, and J. Condeelis Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation J. Cell Biol., August 30, 2004; 166(5): 697 - 708. [Abstract] [Full Text] [PDF]

				S. K. Sukumaran, G. McNamara, and N. V. Prasadarao Escherichia coli K-1 Interaction with Human Brain Micro-vascular Endothelial Cells Triggers Phospholipase C-{gamma}1 Activation Downstream of Phosphatidylinositol 3-Kinase J. Biol. Chem., November 14, 2003; 278(46): 45753 - 45762. [Abstract] [Full Text] [PDF]

				S. M. Thomas, F. M. Coppelli, A. Wells, W. E. Gooding, J. Song, J. Kassis, S. D. Drenning, and J. R. Grandis Epidermal Growth Factor Receptor-stimulated Activation of Phospholipase C{gamma}-1 Promotes Invasion of Head and Neck Squamous Cell Carcinoma Cancer Res., September 1, 2003; 63(17): 5629 - 5635. [Abstract] [Full Text] [PDF]

				A. Mamoune, J.-H. Luo, D. A. Lauffenburger, and A. Wells Calpain-2 as a Target for Limiting Prostate Cancer Invasion Cancer Res., August 1, 2003; 63(15): 4632 - 4640. [Abstract] [Full Text] [PDF]

				R. Iuliano, F. Trapasso, I. Le Pera, F. Schepis, I. Sama, A. Clodomiro, K. R. Dumon, M. Santoro, L. Chiariotti, G. Viglietto, et al. An Adenovirus Carrying the Rat Protein Tyrosine Phosphatase {eta} Suppresses the Growth of Human Thyroid Carcinoma Cell Lines in Vitro and in Vivo Cancer Res., February 15, 2003; 63(4): 882 - 886. [Abstract] [Full Text] [PDF]

				A. D. Thor, S. M. Edgerton, S. Liu, D. H. Moore II, and D. J. Kwiatkowski Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers Clin. Cancer Res., August 1, 2001; 7(8): 2415 - 2424. [Abstract] [Full Text] [PDF]

				C. P. BERRIE and M. FALASCA Patterns within protein/polyphosphoinositide interactions provide specific targets for therapeutic intervention FASEB J, December 1, 2000; 14(15): 2618 - 2622. [Abstract] [Full Text]

				C. S. Swindle, K. T. Tran, T. D. Johnson, P. Banerjee, A. M. Mayes, L. Griffith, and A. Wells Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor J. Cell Biol., July 23, 2001; 154(2): 459 - 468. [Abstract] [Full Text] [PDF]